Panic Disorder
![](https://libapps.s3.amazonaws.com/customers/2337/images/fdadrug_thumbnail.jpg)
The reviews of panic disorder drugs provided data for articles entitledReporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders, Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature, Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression, and Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysis.